Medtronic
Medtronic plc, a global leader in medical technology, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1949, the company has pioneered advancements in various medical fields, including cardiovascular, diabetes, and neurological care. Medtronic is renowned for its innovative core products, such as insulin pumps, cardiac devices, and surgical instruments, which are designed to improve patient outcomes and enhance quality of life. The company’s commitment to research and development has positioned it as a market leader, with notable achievements including the first successful implant of a cardiac pacemaker. With a strong focus on patient-centric solutions, Medtronic continues to set industry standards, making significant contributions to healthcare worldwide.
DitchCarbon Score
How does Medtronic's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medtronic's score of 53 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medtronic's reported carbon emissions
In 2023, Medtronic reported total greenhouse gas emissions of approximately 1,224,000 kg CO2e for Scope 1, 134,400 kg CO2e for Scope 2, and 1,200,000 kg CO2e for Scope 3, amounting to a total of about 2,568,800 kg CO2e across all scopes. The company has set ambitious climate commitments, aiming for carbon neutrality in its operations by FY30 and net-zero emissions across its entire value chain by FY45. Additionally, Medtronic has committed to establishing near-term science-based emissions reduction targets and long-term net-zero goals, aligning with the Science Based Targets initiative (SBTi) standards. In 2021, Medtronic disclosed emissions of approximately 35,570,000 kg CO2e for Scope 1 and 206,947,000 kg CO2e for Scope 2 globally, with Scope 3 emissions reported at about 1,400,000 kg CO2e. The company is actively working towards reducing its carbon footprint and has committed to setting long-term science-based targets to achieve net-zero greenhouse gas emissions by 2050. Medtronic's climate strategy reflects a comprehensive approach to sustainability, focusing on significant reductions in emissions across all scopes, thereby contributing to global efforts to combat climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000 | 000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000 | 000,000 |
| Scope 3 | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medtronic is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
